Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Alexion submits U.S. BLA for ALXN-1210 to treat PNH

June 19, 2018

Catalyst offers update from Cohort 6 in phase I/II trial of CB-2679d for hemophilia B

June 19, 2018

Verseon prepares for phase I study of oral anticoagulant VE-1902

June 14, 2018

MaxCyte and NIH enter CRADA for sickle cell disease

June 11, 2018

FDA approves Mircera for pediatric use

June 8, 2018

FDA grants orphan drug designation to olinciguat for sickle cell disease

June 8, 2018

Biogen enters agreement to acquire stroke drug candidate from TMS

June 8, 2018

Merck & Co. synthesizes new FXIIa inhibitors

June 7, 2018

FDA grants priority review to Hemlibra sBLA

June 5, 2018

Transfusion reductions seen with stem cell gene therapy for beta-thalassemia

June 1, 2018

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...